Skip to content

Ozone Gel Application in Controlled Type 2 Diabetic Patients With Periodontitis

Clinical and Radiographic Evaluation of Non-Surgical Therapy With and Without Ozone Gel Application in Controlled Type 2 Diabetic Patients With Periodontitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05538078
Enrollment
24
Registered
2022-09-13
Start date
2022-10-15
Completion date
2023-08-02
Last updated
2022-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Diseases

Brief summary

The adjunctive topical subgingival application ozone gel creates a great improvements in the clinical, bacteriological and immunological parameters over the gold standard of periodontal pocket treatment alone.

Detailed description

The aim of this study is to compare the effect of using ozone gel as a locally delivered adjunct to scaling and root planning versus scaling and root planning alone on the clinical parameters in stageIII grade B in periodontitis patients with controlled diabetic patients.

Interventions

application of Ozone gel after scaling by ultrasonic scaler in the bottom of periodontal pocket

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Patient with controlled diabetic type II. (HgA1C \<7) (Mori et al., 2021) 2. Adult patients above 18 years old. 3. Patients with stage III and grade B periodontitis. 4. Patients accept 3-months follow-up period (cooperative patients). 5. Patients provide an informed consent

Exclusion criteria

* 1\. Presence of prosthetic crowns. 2. Extensive restorations. 3. Periodontal therapy within the last 12 months. 4. Having surgical therapy or undergoing orthodontic treatment. 5. Ongoing drug therapy that might have an impact on the clinical signs and symptoms of periodontitis. 6\. The use of antibiotics or anti-inflammatory drugs 1 month prior to the procedure and till the end of 3 months of follow-up. 7\. Smokers. 8. Pregnant females. 9. Any known allergies

Design outcomes

Primary

MeasureTime frameDescription
Clinical Attachment Level3monthsclinical attachment gain by using UNC15 Periodontal probe/ numerical data

Secondary

MeasureTime frameDescription
Probing Depth3 monthsmeasuring probing depth by using UNC15 Periodontal probe/numerical data
plaque index3 monthsmeasuring it visually/numerical data
Dentinal Hypersensitivity7 daysmeasuring it using VAS scale
Bleeding on Probing visually/numerical data3 monthsmeasuring it visually/numerical data

Countries

Egypt

Contacts

Primary ContactAbeer A Barahim, BDS
abeer.barahim@dentistry.cu.edu.eg00201501808068
Backup ContactNesma M Shemais, PhD
nesma.shemais@dentostry.cu.edu.eg00201005615697

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026